ID

29182

Description

Open, phase IV clinical trial to compare the immunogenicity and reactogenicity of GSK Biologicals’ Infanrix™ (DTPa) vaccine administered as a booster dose at 4 years of age in preterm vs. full-term children previously primed and boosted with Infanrix™ hexa.

Keywords

Versions (1)
  1. 3/4/18 3/4/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

March 4, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Infanrix Vaccine - 102038

English

Elegibility Questionnaire

1 forms  
Elegibility Question
Description

Elegibility Question

Alias
UMLS CUI-1
C1516637
Did the subject meet all the entry criteria?
Description

Elegibility Question

Data type

boolean

Alias
UMLS CUI [1]
C1516637
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Subjects who the investigator believes that their parents/guardians can and will comply with the requirements of the protocol (e.g., completion of the diary cards, return for follow-up visits) should be enrolled in the study
Description

Subject Compliance Behaviour

Data type

boolean

Alias
UMLS CUI [1]
C1321605
A male or female of 4 years old, that participated and completed all the visits of SB217744/070 and 217744/083 study.
Description

Gender, age, study participation status

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3]
C2348568
Written informed consent obtained from the parent or guardian of the subject.
Description

informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Free of obvious health problems as established by medical history and clinical examination before entering into the study.
Description

Medical history

Data type

boolean

Alias
UMLS CUI [1]
C0262926
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) or planned use during the study period
Description

Investigational product use

Data type

boolean

Alias
UMLS CUI [1]
C0304229
Administration of immunosuppressants or other immune-modifying drugs from birth (for corticosteroids, this will mean prednisone, or equivalent, ≥0,5mg/kg/day. Inhaled and topical steroids are allowed.
Description

immunosuppressants

Data type

boolean

Alias
UMLS CUI [1]
C0021081
Administration of immunoglobulins and/or any blood products since birth or planned administration during the study period.
Description

immunoglobin use

Data type

boolean

Alias
UMLS CUI [1]
C0021022
Administration / planned administration of a vaccine not foreseen by the study protocol during the period starting from birth and ending 30 days after the last dose.
Description

vaccination

Data type

boolean

Alias
UMLS CUI [1,1]
C0042196
UMLS CUI [1,2]
C2347852
Evidence of previous or intercurrent diphtheria, tetanus and pertussis disease.
Description

diphtheria, tetanus, pertussis

Data type

boolean

Alias
UMLS CUI [1]
C0262926
UMLS CUI [2]
C0012546
UMLS CUI [3]
C0039614
UMLS CUI [4]
C0043167
Evidence of previous diphtheria, tetanus and pertussis vaccination at 4 years of age.
Description

diphtheria, tetanus and pertussis vaccination

Data type

boolean

Alias
UMLS CUI [1]
C0012559
History of seizures or progressive neurological disease.
Description

seizure |progressive neurological disease

Data type

boolean

Alias
UMLS CUI [1]
C0036572
UMLS CUI [2,1]
C0027765
UMLS CUI [2,2]
C1335499
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
Description

immunodeficiency

Data type

boolean

Alias
UMLS CUI [1]
C0021051
Major congenital defects or serious chronic illness.
Description

major congenical defects or serious chronic illness

Data type

boolean

Alias
UMLS CUI [1,1]
C0220810
UMLS CUI [1,2]
C0205164
UMLS CUI [2,1]
C0008679
UMLS CUI [2,2]
C0205404
History of allergic disease or reactions likely to be exacerbated by any component of the vaccines.
Description

Medical history of allergic disease

Data type

boolean

Alias
UMLS CUI [1]
C2106654
Acute febrile illness (rectal temperature of ≥ 38ºC) at the time of planned vaccination (warrants deferral of the vaccination pending recovery of the subject).
Description

fever

Data type

boolean

Alias
UMLS CUI [1]
C0015967
Back to the top of the page

Similar models

Elegibility Questionnaire

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Elegibility Question
C1516637 (UMLS CUI-1)
Elegibility Question
Item
Did the subject meet all the entry criteria?
boolean
C1516637 (UMLS CUI [1])
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Subject Compliance Behaviour
Item
Subjects who the investigator believes that their parents/guardians can and will comply with the requirements of the protocol (e.g., completion of the diary cards, return for follow-up visits) should be enrolled in the study
boolean
C1321605 (UMLS CUI [1])
Gender, age, study participation status
Item
A male or female of 4 years old, that participated and completed all the visits of SB217744/070 and 217744/083 study.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C2348568 (UMLS CUI [3])
informed consent
Item
Written informed consent obtained from the parent or guardian of the subject.
boolean
C0021430 (UMLS CUI [1])
Medical history
Item
Free of obvious health problems as established by medical history and clinical examination before entering into the study.
boolean
C0262926 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Investigational product use
Item
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) or planned use during the study period
boolean
C0304229 (UMLS CUI [1])
immunosuppressants
Item
Administration of immunosuppressants or other immune-modifying drugs from birth (for corticosteroids, this will mean prednisone, or equivalent, ≥0,5mg/kg/day. Inhaled and topical steroids are allowed.
boolean
C0021081 (UMLS CUI [1])
immunoglobin use
Item
Administration of immunoglobulins and/or any blood products since birth or planned administration during the study period.
boolean
C0021022 (UMLS CUI [1])
vaccination
Item
Administration / planned administration of a vaccine not foreseen by the study protocol during the period starting from birth and ending 30 days after the last dose.
boolean
C0042196 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
diphtheria, tetanus, pertussis
Item
Evidence of previous or intercurrent diphtheria, tetanus and pertussis disease.
boolean
C0262926 (UMLS CUI [1])
C0012546 (UMLS CUI [2])
C0039614 (UMLS CUI [3])
C0043167 (UMLS CUI [4])
diphtheria, tetanus and pertussis vaccination
Item
Evidence of previous diphtheria, tetanus and pertussis vaccination at 4 years of age.
boolean
C0012559 (UMLS CUI [1])
seizure |progressive neurological disease
Item
History of seizures or progressive neurological disease.
boolean
C0036572 (UMLS CUI [1])
C0027765 (UMLS CUI [2,1])
C1335499 (UMLS CUI [2,2])
immunodeficiency
Item
Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection.
boolean
C0021051 (UMLS CUI [1])
major congenical defects or serious chronic illness
Item
Major congenital defects or serious chronic illness.
boolean
C0220810 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0008679 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
Medical history of allergic disease
Item
History of allergic disease or reactions likely to be exacerbated by any component of the vaccines.
boolean
C2106654 (UMLS CUI [1])
fever
Item
Acute febrile illness (rectal temperature of ≥ 38ºC) at the time of planned vaccination (warrants deferral of the vaccination pending recovery of the subject).
boolean
C0015967 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial